1. Home
  2. AROC vs TLX Comparison

AROC vs TLX Comparison

Compare AROC & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AROC
  • TLX
  • Stock Information
  • Founded
  • AROC 1990
  • TLX 2015
  • Country
  • AROC United States
  • TLX Australia
  • Employees
  • AROC N/A
  • TLX N/A
  • Industry
  • AROC Oil & Gas Production
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AROC Energy
  • TLX Health Care
  • Exchange
  • AROC Nasdaq
  • TLX Nasdaq
  • Market Cap
  • AROC 4.5B
  • TLX 3.6B
  • IPO Year
  • AROC 1997
  • TLX N/A
  • Fundamental
  • Price
  • AROC $24.76
  • TLX $9.90
  • Analyst Decision
  • AROC Buy
  • TLX Strong Buy
  • Analyst Count
  • AROC 6
  • TLX 4
  • Target Price
  • AROC $31.50
  • TLX $21.00
  • AVG Volume (30 Days)
  • AROC 1.9M
  • TLX 100.3K
  • Earning Date
  • AROC 10-28-2025
  • TLX 01-01-0001
  • Dividend Yield
  • AROC 3.39%
  • TLX N/A
  • EPS Growth
  • AROC 65.71
  • TLX N/A
  • EPS
  • AROC 1.50
  • TLX 0.04
  • Revenue
  • AROC $1,439,161,000.00
  • TLX $664,225,558.00
  • Revenue This Year
  • AROC $31.39
  • TLX N/A
  • Revenue Next Year
  • AROC $6.57
  • TLX N/A
  • P/E Ratio
  • AROC $16.49
  • TLX $232.65
  • Revenue Growth
  • AROC 31.94
  • TLX 55.35
  • 52 Week Low
  • AROC $20.12
  • TLX $8.93
  • 52 Week High
  • AROC $30.44
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • AROC 47.30
  • TLX 39.96
  • Support Level
  • AROC $24.61
  • TLX $10.54
  • Resistance Level
  • AROC $25.77
  • TLX $11.00
  • Average True Range (ATR)
  • AROC 0.76
  • TLX 0.21
  • MACD
  • AROC -0.02
  • TLX -0.08
  • Stochastic Oscillator
  • AROC 25.93
  • TLX 8.69

About AROC Archrock Inc.

Archrock Inc is an energy infrastructure company with a focus on midstream natural gas compression and a commitment to helping customers produce, compress, and transport natural gas. It has two business segments, Contract Operations, and Aftermarket Services. Under the umbrella of contract operations services, the company provides operations to meet customers' natural gas compression needs. Services include designing, owning, installing, operating, and maintaining equipment. Aftermarket Services business provides a full range of services to support the compression needs of customers who own compression equipment, including operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components. It generates maximum revenue from the Contract Operations segment.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: